(1999; 168 pages) [Spanish]
9.2 National implementation guidelines for combating counterfeit pharmaceuticals
The Committee noted that this issue was to be discussed at the forthcoming international workshop on counterfeit pharmaceuticals. It recognized that advice on the strategies to be used and types of cooperation required at national and international centres was essential to combat counterfeit pharmaceutical products. The active participation of both the pharmaceutical industry and governments to prevent counterfeiting was highlighted (see also sections 6.3, 6.4 and 11.2).